Volume 13, Number 10—October 2007
Global Poverty and Human Development
Dengue Fever Seroprevalence and Risk Factors, Texas–Mexico Border, 2004
|Serologic test||Brownsville, n||Matamoros, n|
|IgM >0.2 OD†||1||2|
|PRNT90||1 (DEN-2)||2 (DEN-1)|
*IgM, immunoglobulin M; OD, optical density; PRNT, plaque reduction neutralization test; DEN, dengue virus.
†Laboratory-confirmed by the Dengue Branch, Centers for Disease Control and Prevention, defined by antidengue IgG titer >40,960 or IgM >0.2 OD.
‡Laboratory-confirmed by using indirect IgG ELISA (Panbio Inc., Brisbane, Queensland, Australia).
- Page created: July 02, 2010
- Page last updated: July 02, 2010
- Page last reviewed: July 02, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)